The Institute for Molecular Medicine Exclusively Licenses MultiTEP, a Universal Vaccine Platform Technology, to New Biotechnology Company Nuravax

The Institute for Molecular Medicine Exclusively Licenses MultiTEP, a Universal Vaccine Platform Technology, to New Biotechnology Company Nuravax

Associated Press
September 29, 2021, 5:40 am
The Institute for Molecular Medicine (IMM), a non-profit scientific research organization established in 1996 with the goal of understanding, preventing and curing chronic diseases, including neurodegenerative disorders,
Health
Read Article